Harry Penner Jr. is Director at Celldex Therapeutics, Inc. (CLDX). They have made 2 open-market trades across 1 company since 2010, most recently 2017-06-15.
CIK 0001131148
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2010, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLDX | 41,916 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2017-06-16 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.